Patents by Inventor Daxiang Cui

Daxiang Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11692978
    Abstract: Disclosed herein are a group of gastric cancer VOC markers in saliva and an application thereof in the preparation of a diagnostic reagent of gastric cancer. The markers are a combination of compounds selected from the group consisting of acetaldehyde, 2-methylbutyraldehyde, isopropanol, hexanal, n-butanol, cineole, nonanal, menthone, 2-ethylhexanol, menthol, anethole and dodecanol. The diagnostic reagent is used for detecting the contents of the marker in a saliva sample of a subject to perform the diagnosis of gastric cancer.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: July 4, 2023
    Assignee: Shanghai Jiao Tong University
    Inventors: Daxiang Cui, Cuili Xue, Yunsheng Chen
  • Patent number: 11325841
    Abstract: A preparation method of indium oxide with stable morphology includes: (1) mixing indium oxide powder and bismuth oxide powder according to a mass ratio of 1:0.1-0.5 to obtain a powder mixture; (2) putting the powder mixture into a ball mill for ball milling at room temperature to obtain a uniform powder mixture; (3) putting the obtained uniform powder mixture into a muffle furnace and calcining at 700-1000° C.; and (4) obtaining the indium oxide with cubic stable morphology after the muffle furnace naturally cools to room temperature. The method has advantages of simple synthesis process, short synthesis period, high sample yield, no need of complicated equipment, and morphology of the obtained indium oxide can be maintained after being heated at a high temperature within 1000° C. for 2 hours. An electrochemical sensor prepared by using the indium oxide obtained by the method has better selectivity to nonane.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: May 10, 2022
    Assignee: SHANGHAI JIAO TONG UNIVERSITY
    Inventors: Han Jin, Daxiang Cui, Cuili Xue, Yuna Zhang, Yuli Xv, Yuan Zhou
  • Publication number: 20220098052
    Abstract: A preparation method of indium oxide with stable morphology includes: (1) mixing indium oxide powder and bismuth oxide powder according to a mass ratio of 1:0.1-0.5 to obtain a powder mixture; (2) putting the powder mixture into a ball mill for ball milling at room temperature to obtain a uniform powder mixture; (3) putting the obtained uniform powder mixture into a muffle furnace and calcining at 700-1000° C.; and (4) obtaining the indium oxide with cubic stable morphology after the muffle furnace naturally cools to room temperature. The method has advantages of simple synthesis process, short synthesis period, high sample yield, no need of complicated equipment, and morphology of the obtained indium oxide can be maintained after being heated at a high temperature within 1000° C. for 2 hours. An electrochemical sensor prepared by using the indium oxide obtained by the method has better selectivity to nonane.
    Type: Application
    Filed: September 23, 2021
    Publication date: March 31, 2022
    Inventors: Han Jin, Daxiang Cui, Cuili Xue, Yuna Zhang, Yuli Xv, Yuan Zhou
  • Publication number: 20200348269
    Abstract: Disclosed herein are a group of gastric cancer VOC markers in saliva and an application thereof in the preparation of a diagnostic reagent of gastric cancer. The markers are a combination of compounds selected from the group consisting of acetaldehyde, 2-methylbutyraldehyde, isopropanol, hexanal, n-butanol, cineole, nonanal, menthone, 2-ethylhexanol, menthol, anethole and dodecanol. The diagnostic reagent is used for detecting the contents of the marker in a saliva sample of a subject to perform the diagnosis of gastric cancer.
    Type: Application
    Filed: April 30, 2020
    Publication date: November 5, 2020
    Inventors: Daxiang CUI, Cuili XUE, Yunsheng CHEN
  • Patent number: 10781446
    Abstract: The presently-disclosed subject matter relates to RNA-based composition and method to treat gastric cancer in a subject. More particularly, the presently disclosed subject matter relates to a RNA nanostructure and composition containing a multiple branched RNA nanoparticle, a gastric cancer targeting module, and an effective amount of a therapeutic agent. Further, the presently disclosed subject matter relates to a method of using the RNA nanoparticle composition to treat gastric cancer in a subject having or at risk of having gastric cancer.
    Type: Grant
    Filed: March 9, 2016
    Date of Patent: September 22, 2020
    Assignee: University of Kentucky Research Foundation
    Inventors: Peixuan Guo, Daxiang Cui, Dan Shu, Yi Shu, Chunlei Zhang
  • Publication number: 20190032050
    Abstract: The presently-disclosed subject matter relates to RNA-based composition and method to treat gastric cancer in a subject. More particularly, the presently disclosed subject matter relates to a RNA nanostructure and composition containing a multiple branched RNA nanoparticle, a gastric cancer targeting module, and an effective amount of a therapeutic agent. Further, the presently disclosed subject matter relates to a method of using the RNA nanoparticle composition to treat gastric cancer in a subject having or at risk of having gastric cancer.
    Type: Application
    Filed: March 9, 2016
    Publication date: January 31, 2019
    Inventors: Peixuan Guo, Daxiang Cui, Dan Shu, Yi Shu, Chunlei Zhang
  • Publication number: 20140244229
    Abstract: Volatile organic compounds emitted from gastric cancer cell metabolite is separated and detected using HS-SPME/GC-MS. A volatile compounds fingerprint atlas-spectrum model are disclosed for early gastric cancer diagnosis/warning Volatiles 3-octanone and 2-butanone as indicators of gastric cancer cells which are not contained in the headspace of gastric mucosal cells GES-1. Meanwhile, the ratio of mass to volume to concentration of 4-isopropoxy alcohol, nonanoic acid, and 4-butoxy n-butanol is as follows: 4-isopropoxy alcohol [gastric cancer cells]/[normal gastric mucosa cells]?0.31; nonanoic acid [gastric cancer cells]/[normal gastric mucosa cells]?0.36; and 4-butoxy n-butanol [gastric cancer cells]/[normal gastric mucosa cells]?0.40. The volatile organic compound in cell metabolite to be detected is compared with the fingerprint atlas-spectrum model, so as to implement screening and warning of the early gastric cancer.
    Type: Application
    Filed: January 17, 2012
    Publication date: August 28, 2014
    Inventors: Yixia Zhang, Daxiang Cui